Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety and Tolerability of Pradigastat in Patients With Functional Constipation

NCT04620161 is registered in ClinicalTrials.gov with Anji Pharma as lead sponsor.

NCT NCT04620161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety and Tolerability of Pradigastat in Patients With Functional Constipation
Lead sponsor
Anji Pharma
Phase
Phase 2
Overall status
Completed
Start date
September 22, 2020
Completion date
June 3, 2022
Enrollment
181 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

functional constipation